Postoperative active specific immunotherapy with supportive measures in patients suffering from recurrent metastasized melanoma: Case reports of six patients
- 1 October 1986
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 33 (2) , 115-119
- https://doi.org/10.1002/jso.2930330213
Abstract
The clinical results from postoperative active specific immunotherapy using autologous polymerized tumor material in six patients suffering from metastasized melanoma is reported. Correction of an alleged systemic deficiency leading to malignant cell transformation was attempted by administrating certain essential trace elements, amino acids, vitamins, and a diet containing lipids, extracted from the mammalian central nervous system, after heating. Vaccinations against influenza were also given as a precaution against certain viral infections sometimes seen to precede melanoma recurrence. The clinical results with this postoperative adjuvant therapy are so encouraging that we suggest that sterile tumor tissue should be saved at operation and treated to produce insoluble particles as an option for postoperative treatment of patients suffering from metastasized melanoma. Prospective randomized studies are indicated.Keywords
This publication has 4 references indexed in Scilit:
- The natural history of resectable metastatic melanoma (Stage IVA Melanoma)Cancer, 1982
- Immunological Studies Using Insoluble Protein PolymersPublished by Elsevier ,1971
- Biologically Active Water-insoluble Protein PolymersJournal of Biological Chemistry, 1967
- BIOLOGICALLY ACTIVE WATER-INSOLUBLE PROTEIN POLYMERS .I. THEIR USE FOR ISOLATION OF ANTIGENS AND ANTIBODIES1967